KalVista Pharmaceuticals, Inc. ($KALV)
Filing Information
| Accession Number | 0001827505-26-000007 |
|---|---|
| Form Type | 4 |
| Filing Date | Jun 11, 2026 |
| Document | View SEC Filing |
Transactions
5
Total Shares
361,791
Total Value
$0.00
Transactions
| Name | Title | Security | Derivative | Transaction Date | Type | Shares | Price | Total Cost | Shares After | Direct/Indirect | Nature of Ownership | Actions |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
Chief Commercial Officer | Common Stock | โ | Jun 11, 2026 | Sale to Issuer | 59,291 | $0.00 | $0.00 | 0 | Direct | โ | View Details | |
Chief Commercial Officer | Stock Option (Right to Buy) | Derivative | Jun 11, 2026 | Sale to Issuer | 100,000 | โ | โ | 0 | Direct | โ | View Details | |
Chief Commercial Officer | Restricted Stock Unit | Derivative | Jun 11, 2026 | Sale to Issuer | 40,000 | โ | โ | 0 | Direct | โ | View Details | |
Chief Commercial Officer | Restricted Stock Unit | Derivative | Jun 11, 2026 | Sale to Issuer | 68,750 | โ | โ | 0 | Direct | โ | View Details | |
Chief Commercial Officer | Restricted Stock Unit | Derivative | Jun 11, 2026 | Sale to Issuer | 93,750 | โ | โ | 0 | Direct | โ | View Details |